FIELD: medicine.
SUBSTANCE: invention relates to thiophene derivatives corresponding to the following formula (I):
,
where each symbol is such as defined in the claims, or its pharmaceutically acceptable salt, which have activity of suppression of TNF-α production and activity of inhibition of proliferation of hematological malignant cells, and it is suitable for the treatment of rheumatoid arthritis, Crohn’s disease, ulcerative colitis, and, in addition, hematological malignant tumor.
EFFECT: obtaining thiophene derivatives for the treatment of diseases.
24 cl, 2 tbl, 56 ex
Title | Year | Author | Number |
---|---|---|---|
CYCLOALKYL NITRILE PYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2655380C2 |
ARYLMETHOXY ISOINDOLIN DERIVATIVE, COMPOSITIONS INCLUDING THEREOF AND METHODS OF THEIR APPLICATION | 2011 |
|
RU2567753C2 |
TRICYCLIC HETEROCYCLIC COMPOUNDS AND JAK INHIBITORS | 2012 |
|
RU2632870C2 |
NOVEL COMPOUNDS AS HISTONE DEACETYLASE 6 INHIBITOR AND PHARMACEUTICAL COMPOSITION CONTAINING THEREOF | 2021 |
|
RU2817736C1 |
THIENOPYRIMIDINE COMPOUNDS AND THEIR APPLICATION | 2004 |
|
RU2331648C2 |
NOVEL BENZAMIDE DERIVATIVES | 2011 |
|
RU2536688C2 |
GLYCOLATOXIDASE INHIBITORS FOR THE TREATMENT OF DISEASES | 2018 |
|
RU2805308C2 |
PIPERAZINE COMPOUND INHIBITING PROSTAGLANDIN-D-SYNTHASE | 2010 |
|
RU2496778C2 |
PRIMARY AMINE DIAZENIUMDIOLATE HETEROCYCLIC DERIVATIVES | 2012 |
|
RU2596867C2 |
GEMINALLY SUBSTITUTED CYANOETHYLPYRAZOLO PYRIDONES AS JANUS KINASE INHIBITORS | 2014 |
|
RU2664533C2 |
Authors
Dates
2022-10-17—Published
2019-01-25—Filed